Tuesday, December 5, 2023
WebMD Global requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated. Others involved in the planning of this activity have no relevant financial relationships with ineligible companies.
Disclosures for additional planners can be found here.
General Practitioner
National Immunization Lead
Royal College of General Practitioners
President
British Global and Travel Health Association
London, United Kingdom
Professor in Physical Pharmacy and Biopharmacy
Ghent University
Head of the Ghent Research Group on Nanomedicines
Ghent, Belgium
This activity has been peer reviewed and the reviewer has disclosed no relevant financial relationships.
This activity is intended for a non-US audience of primary care physicians, infectious diseases specialists, pediatricians, pharmacists, and nurses.
The goal of this activity is to increase knowledge regarding the pathology of SARS-CoV-2, the scientific basis for the messenger ribonucleic acid (mRNA) vaccines, and the key variances between the different COVID-19 vaccine platforms.
Upon completion of this activity, participants will:
WebMD Global requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated. Others involved in the planning of this activity have no relevant financial relationships with ineligible companies.
Disclosures for additional planners can be found here.
General Practitioner
National Immunization Lead
Royal College of General Practitioners
President
British Global and Travel Health Association
London, United Kingdom
Professor in Physical Pharmacy and Biopharmacy
Ghent University
Head of the Ghent Research Group on Nanomedicines
Ghent, Belgium
This activity has been peer reviewed and the reviewer has disclosed no relevant financial relationships.
The Faculty of Pharmaceutical Medicine of the Royal Colleges of Physicians of the United Kingdom (FPM) has reviewed and approved the content of this educational activity and allocated it 0.50 continuing professional development credits (CPD).
For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]
There are no fees for participating in or receiving credit for this online educational activity. For information about your
eligibility to claim
credit, please consult your professional licensing board.
This activity is designed to be completed within the time designated on the title page; physicians should claim only those
credits that reflect the
time actually spent participating in the activity. To successfully earn credit, participants must complete the activity online
during the credit
eligibility period that is noted on the title page.
Follow these steps to claim a credit certificate for completing this activity:
We encourage you to complete an Activity Evaluation to provide feedback for future programming.
You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it.
Credits will be tallied
in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well
as the certificates by
accessing "Edit Your Profile" at the top of your Medscape homepage.
*The credit that you receive is based on your user profile.
CPD Released: 2/4/2022
Valid for credit through: 2/4/2023, 11:59 PM EST
processing....
Note: The information on the coronavirus outbreak is continually evolving. The content within this activity serves as a historical reference to the information that was available at the time of this publication. We continue to add to the collection of activities on this subject as new information becomes available. It is the policy of Medscape Education to avoid the mention of brand names or specific manufacturers in accredited educational activities. However, manufacturer names related to the approved COVID-19 vaccines are provided in this activity in an effort to promote clarity. The use of manufacturer names should not be viewed as an endorsement by Medscape of any specific product or manufacturer.
The goal of this activity is to increase knowledge regarding the pathology of SARS-CoV-2, the scientific basis for the messenger ribonucleic acid (mRNA) vaccines, and the key variances between the different COVID-19 vaccine platforms.
Before you begin this activity, please assess your clinical knowledge by completing this brief survey. Answering these questions again after the activity will allow you to see what you learned and to compare your answers with those of your peers.
